- Do more for less with Intelli-ion®: Elevating anti-corrosion coatings with low loadings
- Innovative polycarbonates for lighting and building technology
- Maximising corrosion protection and preservation at grease points
- PPG to review strategic alternatives for architectural coatings business in the USA and Ca...
- UK coatings industry’s Net Zero Roadmap awarded Publication of the Year at the 2024 Trad...
· Sales up 33.5% yr-on-yr at €1.951bn
· EBITDA pre exceptionals increase 44.0% to €278M
· Earnings increase in all segments – Specialty Additives and Engineering Materials particularly strong
· Increased raw material prices successfully passed on, but rising energy prices and high freight costs weigh on earnings
· EBITDA pre exceptionals for 2021 expected to be at the lower end of the guided range of €1bn to €1.05bn
· Growth continues: acquisition of IFF Microbial Control announced
Speciality chemicals company LANXESS holds its own also in a challenging environment: Despite a sharp rise in raw material, energy and freight costs, EBITDA pre exceptionals in Q3 2021 increased by 44.0% to €278M, against €193M in the prior-year quarter.The strong earnings were driven by all segments – especially Specialty Additives and Engineering Materials. LANXESS passed on the significantly increased raw material prices via higher selling prices. The three acquisitions completed in this fiscal year, especially that of Emerald Kalama Chemical, also contributed to the good results. Adverse exchange rates, mainly from the U.S. dollar, but especially higher energy and freight costs prevented a further increase in earnings. The EBITDA margin pre exceptionals increased to 14.2% in Q3, against 13.2% in the prior-year quarter."The third quarter of this year was again characterised by growth. Our operating business continued to develop positively, and we successfully passed on the significantly increased raw material costs. With the announced acquisition of IFF Microbial Control, we will also be significantly expanding our Consumer Protection segment again in the future.
This will make us more stable and more profitable,” said Matthias Zachert, Chairman of the Board of Management of LANXESS AG. "However, the unprecedented increase in energy, raw material and freight costs is not leaving us unscathed. We expect the cost pressure to even increase in the fourth quarter.” Due to these cost increases, strained supply chains and power rationing in China, which is having a negative effect on production there, LANXESS expects EBITDA pre exceptionals for the full year to be at the lower end of the guided range of €1bn to €1.05bn.With an increase of 33.5% yr-on-yr, LANXESS generated sales of €1.951bn in Q3 2021. At €68M, net income from continuing operations was higher than in Q3 2020, in which LANXESS generated €25M. This was due to the good development of the operating businesses and the contribution of Emerald Kalama Chemical.
Consumer Protection segment continues to grow
LANXESS continues to grow with the planned acquisition of the Microbial Control business from U.S. group International Flavors & Fragrances Inc. (IFF). The two companies signed an agreement to this effect in August. The transaction is scheduled to be completed in the second quarter of 2022. IFF Microbial Control is one of the leading suppliers of antimicrobial active ingredients and formulations for material protection, preservatives and disinfectants.The company generates annual sales of around US$450M (around €380M*) and EBITDA of roughly US$100M (roughly €85M*). Within four years of the completion of the transaction, LANXESS expects an additional annual EBITDA contribution of around US$35M (roughly €30M*) as a result of synergies.
Segments: Increasing demand and prices drive earnings
Thanks to higher selling prices due to the passing on of increased raw material costs and continued good demand, the Advanced Intermediates segment posted higher sales in the third quarter of 2021. They rose by 28.7% from €414M to €533M. The segment’s EBITDA pre exceptionals reached €84M, 18.3% higher than the prior-year figure of €71M, even though earnings were burdened by energy prices, which increased particularly in this segment, as well as higher freight costs and adverse exchange rate effects. The EBITDA margin pre exceptionals declined to 15.8%, against 17.1% in the prior-year quarter.The Specialty Additives segment benefited from higher selling prices and improved demand in all business units. Sales in Q3 2021 grew by 29.8% from €466M to €605M. Although earnings were burdened by increased freight costs and adverse exchange rate effects, EBITDA pre exceptionals was up 72.9% on the prior-year level of €59M. At €102M, the segment even achieved the best result in its history. The EBITDA margin pre exceptionals reached 16.9%, against 12.7% a year ago.The Consumer Protection segment’s sales and earnings developed positively in Q3 2021. This is particularly attributable to the new Flavors & Fragrances business unit, which was established at the beginning of August with the acquisition of Emerald Kalama Chemical.The acquisitions of Theseo and INTACE and higher selling prices also had a positive effect. Sales grew by 27.0% to €353M, against €278M in the previous year.The positive earnings contribution from Emerald Kalama Chemical was almost offset by significantly increased energy and freight costs and an unplanned production shutdown at Saltigo.
The segment’s EBITDA pre exceptionals of €60M was thus only 1.7% higher than the prior year quarter’s figure of €59M. The EBITDA margin pre exceptionals reached 17.0%, against 21.2% a year ago.Due to higher selling prices and increased sales volumes, the Engineering Materials segment generated significantly higher sales; this was due in particular to the continued very good demand from the automotive industry. Sales increased by 53.0% from €285M in Q3 of the previous year, which was heavily affected by the pandemic, to €436M.Although higher energy and freight costs had a negative effect on earnings, EBITDA pre exceptionals in this segment increased by 87.9% from €33M to €62M. The EBITDA margin pre exceptionals thus amounted to 14.2%, against 11.6% a year ago.